OLIN Corp OLN
NYSE · XNYS · stock · Chemicals & Allied Products
Chart by TradingView
4/9
Piotroski F — financial health
1.62
Altman Z″ — distress risk · grey
-90.6%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $6.8B | -$101.1M | $501.5M | $247.9M | $1.8B |
| 2024 | $6.5B | $105.0M | $737.5M | $308.1M | $2.0B |
| 2023 | $6.8B | $452.0M | $1.2B | $738.3M | $2.2B |
| 2022 | $9.4B | $1.3B | $2.2B | $1.7B | $2.5B |
| 2021 | $8.9B | $1.3B | — | $1.5B | $2.7B |
| 2020 | $5.8B | -$969.9M | — | $134.1M | $1.5B |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.62 (grey)
- Working capital / assets 0.047
- Retained earnings / assets 0.292
- EBIT / assets 0.001
- Equity / liabilities 0.337
Source: SEC EDGAR filings · CIK 0000074303 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.